Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 1
2020 1
2022 1
2023 4
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
Padmapriyadarsini C, Oswal VS, Jain CD, Mariappan MV, Singla N, Kumar S, Daniel BD, Dave JD, Vadgama P, Ramraj B, Kant S, Bhatnagar AK, Shanmugam S, Paul D, Bharathi J, Palav M, Shah NV, Santhanakrishnan R, Dewan RK, Shekh N, Rathinam P, Sisara AB, Mankar SD, Bajpai J, Mittal U, Chauhan S, Kumar R, Parmar M, Mattoo SK, Jaju J; modified BPaL (mBPaL) Study Team. Padmapriyadarsini C, et al. Clin Infect Dis. 2024 Dec 17;79(6):1375-1385. doi: 10.1093/cid/ciae388. Clin Infect Dis. 2024. PMID: 39194339 Clinical Trial.
Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.
Padmapriyadarsini C, Vohra V, Bhatnagar A, Solanki R, Sridhar R, Anande L, Muthuvijaylakshmi M, Bhatia M, Jeyadeepa B, Taneja G, Balaji S, Shah P, Saravanan N, Chauhan V, Kumar H, Ponnuraja C, Livchits V, Bahl M, Alavadi U, Sachdeva KS, Swaminathan S; for BEAT India Team. Padmapriyadarsini C, et al. Among authors: alavadi u. Clin Infect Dis. 2022 Jun 29;76(3):e938-46. doi: 10.1093/cid/ciac528. Online ahead of print. Clin Infect Dis. 2022. PMID: 35767251 Free PMC article.
Establishing proof of concept for utility of Trueprep®-extracted DNA in line-probe assay testing.
Rajendran P, Saini S, Kumar N, Vashistha H, Thiruvengadam K, Ramamoorthy T, Gopalaswamy R, Kayesth J, Alavadi U, Moore M, Joshi RP, Ramachandran R, Anand S, Shanmugam S, Padmapriyadarsini C. Rajendran P, et al. Among authors: alavadi u. Int J Tuberc Lung Dis. 2023 Oct 1;27(10):742-747. doi: 10.5588/ijtld.23.0003. Int J Tuberc Lung Dis. 2023. PMID: 37749831 Free PMC article.
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens.
Sachdeva KS, Arora N, Solanki R, Singla R, Sarin R, Bhatnagar A, Khanna A, Atahavale A, Shridhar R, Barua SR, Parmar M, Farooq SI, Ramachandran R, Alavadi U, Swamickan R, Tonsing J, Patel Y, Singla N. Sachdeva KS, et al. Among authors: alavadi u. Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1067-1072. doi: 10.5588/ijtld.20.0136. Int J Tuberc Lung Dis. 2020. PMID: 33126941
Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India.
Gopalaswamy R, Kumar N, Vashistha H, Rajendran P, Kayesth J, Peravali CJ, Kashyap S, Ghosh S, Yumo H, Moore M, Anand S, Ramachandran R, Alavadi U, Saini S, Shanmugam S. Gopalaswamy R, et al. Among authors: alavadi u. Front Public Health. 2023 Oct 10;11:1255756. doi: 10.3389/fpubh.2023.1255756. eCollection 2023. Front Public Health. 2023. PMID: 37886056 Free PMC article.
Experience of "One Stop TB Diagnostic Solution" Model in Engaging a Private Laboratory for End-to-End Diagnostic Services in the National TB Elimination Program in Hisar, India.
Raju R, Prasad BM, Alavadi U, Saini S, Sabharwal M, Duhan A, Anand S, Lal M, Kaur H, Arora N, Jaju J, Moore M, Ramachandran R, Kumar N, Joshi RP. Raju R, et al. Among authors: alavadi u. Diagnostics (Basel). 2023 Aug 31;13(17):2823. doi: 10.3390/diagnostics13172823. Diagnostics (Basel). 2023. PMID: 37685361 Free PMC article.
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
Raizada N, Sachdeva KS, Sreenivas A, Vadera B, Gupta RS, Parmar M, Kulsange S, Babre A, Thakur R, Gray C, Ramachandran R, Alavadi U, Ghedia M, Vollepore B, Dewan P, Boehme C, Paramsivan CN. Raizada N, et al. Among authors: alavadi u. PLoS One. 2014 Feb 26;9(2):e89301. doi: 10.1371/journal.pone.0089301. eCollection 2014. PLoS One. 2014. PMID: 24586675 Free PMC article.
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N, Sachdeva KS, Nair SA, Kulsange S, Gupta RS, Thakur R, Parmar M, Gray C, Ramachandran R, Vadera B, Ekka S, Dhawan S, Babre A, Ghedia M, Alavadi U, Dewan P, Khetrapal M, Khanna A, Boehme C, Paramsivan CN. Raizada N, et al. Among authors: alavadi u. PLoS One. 2014 Aug 20;9(8):e105346. doi: 10.1371/journal.pone.0105346. eCollection 2014. PLoS One. 2014. PMID: 25140877 Free PMC article.
11 results